| Description | EBF4 Human Pre-designed siRNA Set A contains three designed siRNAs for EBF4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control. Components EBF4 siRNA-1: 5 nmol (HPLC) EBF4 siRNA-2: 5 nmol (HPLC) EBF4 siRNA-3: 5 nmol (HPLC) siRNA Negative Control: 5 EBF4 Human Pre-designed siRNA Set A contains three designed siRNAs for EBF4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control. Components EBF4 siRNA-1: 5 nmol (HPLC) EBF4 siRNA-2: 5 nmol (HPLC) EBF4 siRNA-3: 5 nmol (HPLC) siRNA Negative Control: 5 nmol (HPLC) FAM-labeled siRNA Negative Control: 5 nmol (HPLC) GAPDH siRNA Positive Control:5 nmol (HPLC)... Read More | Purity>95% (SDS-PAGE&HPLC) Endotoxin level<1.0 EU/µgFunctionBifunctional growth-modulating glycoprotein. Inhibits growth of several human carcinoma cells in culture and stimulates proliferation of human fibroblasts and certain other tumor cells | Purity≥ 98% SDS-PAGE.FunctionInvolved in the suppression of bile acid biosynthesis through down-regulation of CYP7A1 expression, following positive regulation of the JNK and ERK1/2 cascades. Stimulates glucose uptake in adipocytes. Activity requires the presence of KLB | VEGF permeability factor, also known as Vascular permeability factor (VPF), is a highly specific permeability factor for endothelial growth factor. It can promote the increase of vascular permeability, extracellular matrix degeneration, vascular endothelial cell migration, proliferation and VEGF permeability factor, also known as Vascular permeability factor (VPF), is a highly specific permeability factor for endothelial growth factor. It can promote the increase of vascular permeability, extracellular matrix degeneration, vascular endothelial cell migration, proliferation and angiogenesis. VEGF has also been shown to have chemotaxis on monocytes and osteoblasts.OsrhVEGF is expressed by oryza sativa and purified by protein purification technology... Read More | Inquire |